MRD / Regn No. : SG004688 Date : 20/07/2026
Patient Name : Anita Dugar Age & Gender : 71 Yrs. / Female
Contact No. : 9433049311 UHID :
Ht / Wt / BMI : 167 / 67 / 24.02 BP S / BP D : 126 / 73
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (20/Jul/2006) | CABG (20/Jul/2010) | HYPERTENSION (20/Jul/2026) | HFPEF (20/Jul/2026) | DYSLIPIDEMIA (20/Jul/2026) | UTI (20/Jul/2026) |
Plan : SGLT-2I STOPPED IN VIEW OF ACTIVE UTI  
Salient Investigations : TGL TRIGLYCERIDE: 250 mg/dL | CREATININE: 0.59 | EGFR EGLOMERULAR FILTRATION RATE: 107.54 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 163 mg/dL | HB HEMOGLOBIN: 13.2 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8.5 % | LDL LOW DENSITY LIPOPROTEIN: 43 mg/dL | MICROALBUMIN CREATININE RATIO: 78.41 mcg/mg | POTASSIUM: 4.77
S# Generic (Trade) Name Route Dosage Usage Duration
1 ASPIRIN 75 MG + ATORVASATAIN 40 MG
ECOSPRIN AV 40 MG
PO 0-0-1 AFTER DINNER
TILL NEXT VISIT
2 TABLET FINERENONE 10 MG
LYVELSA 10 MG
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
3 TELMISARTAN 40
TELMA
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
4 GLICLAZIDE 80 MG + METFORMIN 500 MG
GLIZID M
PO 1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
5 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL
SQ 0-0-30 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
6 SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC
ONCE A WEEK AFTER BREAKFAST
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 20/Jan/2027
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,CREATININE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: